secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alzamend Neuro, Inc. (ALZN)
CIK:        0001677077
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0001214659-25-007204
Event type: other_material
Sentiment:  negative
Materiality: 0.50
Item codes: 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alzamend Neuro announces 1-for-9 reverse stock split effective May 12 to maintain Nasdaq listing
--------------------------------------------------------------------------------

- Shares outstanding reduce from ~7,208,591 to ~800,954 at 1-for-9 ratio.
- Split effective May 12, 2025; trading symbol remains ALZN with new CUSIP 02262M605.
- Reverse split aimed at complying with Nasdaq $1.00 minimum bid price requirement.
- No fractional shares issued; holders of fractional shares will receive cash payment.
- Par value unchanged at $0.0001 per share; all options/warrants proportionally adjusted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1677077/000121465925007204/0001214659-25-007204-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1677077/000121465925007204/z572538k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-25-007204

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer